Longboard Pharmaceuticals, Inc. (LBPH) Misses Q3 EPS by 2c

Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q3 EPS of ($0.68), $0.02 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Keurig Dr Pepper coffee chief to depart ahead of planned split
• Bristow Group to acquire Berry Aviation for $105 million